Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Clinical trial NCT03721705 · COMPLETED

Trial details

NCT number: NCT03721705
Sponsor: Renew Research, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease Cognitive Dysfunction Mild Cognitive Impairment Mild Dementia Cognitive Decline Dementia, Alzheimer Type

Start date: 2018-11-12
Primary completion: 2021-03-23
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.